Brehler, Ann-Christin E.
Bauer, Andrea
Wedi, Bettina
Funding for this research was provided by:
Medizinische Hochschule Hannover (MHH)
Article History
Received: 19 June 2023
Accepted: 3 July 2023
First Online: 22 September 2023
Conflict of interest
: A.-C.E. Brehler declares that there are no conflicts of interest. A. Bauer is or has been a presenter and/or advisor and/or has received research support from Novartis, Genentec, Leo, Sanofi, Regeneron, Shire, Takeda, Amgen, AstraZeneca, Abbvie, Celldex, Lilly, Pharvaris, Almirall, L’Oreal, Incyte, Blueberry Therapeutics, Centogene, Galderma and Biofrontera. B. Wedi has received honoraria for lectures and multihour advisory boards, respectively, as well as funding for travel/congress attendance in the last three years from: ALK-Abelló, Bencard, Biocryst, CSL Behring, HAL Allergy, Kalvista, Novartis, Takeda and ThermoFisher Scientific.